Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × X-Rays × 30 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 6 Leukemia, Myeloid, Acute 6 Rhabdoid Tumor 5 Glioma 5 Wilms Tumor 4 Sarcoma 4 Osteosarcoma 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Neuroblastoma 4 Multiple Myeloma 4 Medulloblastoma 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Lung Neoplasms 4 Histiocytosis, Langerhans-Cell 4 Hepatoblastoma 4 Ependymoma 4 Central Nervous System Neoplasms 4 Rhabdomyosarcoma 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Mouth Neoplasms 3 Lymphoma, T-Cell 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Sarcoma, Ewing 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

fludarabine phosphate 5 asciminib 5 Cyclophosphamide 5 fludarabine 4 Melphalan 3 ruxolitinib 2 nilotinib 2 bosutinib 2 Whole-Body Irradiation 2 Thiotepa 2 Tacrolimus 2 Sirolimus 2 Mycophenolic Acid 2 Imatinib Mesylate 2 Granulocyte Colony-Stimulating Factor 2 Dasatinib 2 thymoglobulin 1 plerixafor 1 olverembatinib 1 blinatumomab 1 aldesleukin 1 Specimen Handling 1 Resistance Training 1 Mesna 1 Magnetic Resonance Spectroscopy 1 Health Promotion 1 Filgrastim 1 Educational Status 1 Clinical Trials, Phase I as Topic 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡